Protecting Sensitive Information in Life Sciences Organizations: Top Three Misconceptions That Put Companies at Risk

Free registration required

Executive Summary

Critical business processes in biotech and pharmaceutical companies involve highly confidential, important documents that need to be safely accessed by external partners and potential licensees. Poor security measures based on a "Traditional" view of data security have lead to high-profile, significant security breaches. The technology implemented to ensure security in this new era of business must change. What's needed is a shift in the way business users think about security. Putting confidential information outside the firewall is actually safer and more expedient for all parties involved. Fortunately, there are solutions today that understand this new paradigm and are providing new ways to conduct important business securely without being impeded by IT complexity.

  • Format: PDF
  • Size: 282.6 KB